Methyl iodide → N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-(1-methyl-2-piperidyl)-6-oxo-pyrimidine-4-carboxamide
反応式
C([O:9][C:10]1[C:15](=[O:16])[N:14]([CH3:17])[C:13]([CH:18]2[CH2:23][CH2:22][CH2:21][CH2:20][NH:19]2)=[N:12][C:11]=1[C:24]([O:26]C)=O)(=O)C1C=CC=CC=1.[CH2:28](OC(N1CCCCC1C(O)=O)=O)C1C=CC=CC=1.C(N(CC)CC)C.CI.[F:56][C:57]1[CH:64]=[CH:63][C:60]([CH2:61][NH2:62])=[CH:59][CH:58]=1>C1COCC1.C(#N)C.O>[F:56][C:57]1[CH:64]=[CH:63][C:60]([CH2:61][NH:62][C:24]([C:11]2[N:12]=[C:13]([CH:18]3[CH2:23][CH2:22][CH2:21][CH2:20][N:19]3[CH3:28])[N:14]([CH3:17])[C:15](=[O:16])[C:10]=2[OH:9])=[O:26])=[CH:59][CH:58]=1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
Methyl 5-(benzoyloxy)-1-methyl-6-oxo-2-piperidin-2-yl-1,6-dihydropyrimidine-4-carboxylate (prepared from 1-(benzyloxycarbonyl)piperidine-2-carboxylic acid by procedures similar to those set forth in Examples 1 or 2 in combination with a deprotection step) was suspended in THF and treated with 3 eq. of triethylamine and 3 eq. of methyl iodide at 40° C. After stirring for 5 h, THF was evaporated and residue poured into EtOAc and washed with brine. Organic phase was dried (Na2SO4), filtered and concentrated under reduced pressure. The oily residue was taken into EtOAc and treated with 3 eq. of 4-fluorobenzylamine at 90° C. for 0.5 h. The title product was isolated as its trifluoroacetic salt by preparative RP-HPLC (C18, 5 μM, acetonitrile/water containing 0.1% TFA as eluant).
後処理
- customTHF was evaporated
- additionresidue poured into EtOAc
- washwashed with brine
- dry with materialOrganic phase was dried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated under reduced pressure
出典と根拠
- ORDレコード
- ord-47a9f06b87b142779075a6328f46045c
- 出典データセット
- uspto-grants-2007_01
- 特許番号
- US07169780B2
反応ノート
読み込み中…